BBP
Virtus Biotech ETF Equity
Virtus
·Est. 2014
·US
·
virtus.com/products/virtus-biotech-etf#shareclass./period.quarterly
·
← All ETFs
$87.03
-3.72%
(-3.37)
AUM $61.1M
Expense 34.00%
52w Low $53.12
90.9% of range
52w High $90.42
50d MA $83.93
200d MA $76.75
NAV
$87.29
AUM
$61.1M
Expense
34.00%
Holdings
198
Avg Volume
2K
Inception
Dec 16, 2014
Issuer
Virtus
Exchange
—
Domicile
US
ISIN
US26923G2021
50d MA
$83.93
200d MA
$76.75
About
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index, which tracks the performance of biotechnology companies with at least one drug therapy approved by the FDA.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Products ETF to Virtus Biotech ETF.
Sector Exposure
Healthcare
100.0%